PlainPill

Mirtazapine

Also known as Remeron

The short answer. People are split on Mirtazapine — 52% of 58 say it helped. It is most often used for sleep: 86% of 37 reports say that improved. It is well studied — 174 meta-analyses on PubMed. The most common complaint is drowsiness.

What users report
52%helped58 reports · medium confidence
30 helped16 mixed12 didn't help

From 93 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
174
meta-analyses
262
RCTs
2,966
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Mirtazapine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 174 meta-analyses on PubMed ↗ · 262 randomized trials ↗

Lancet · 2018 · Meta-analysis / systematic review
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Conclusion: All antidepressants were more efficacious than placebo in adults with major depressive disorder. Smaller differences between active drugs were found when placebo-controlled trials were included in the analysis, whereas there was more variability in efficacy and acceptability in head-to-head trials. These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants.

PubMed 29477251 ↗
J Affect Disord · 2022 · Meta-analysis / systematic review
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis

Conclusion: This NMA suggests a superiority of the regulatory approved adjunctive atypical antipsychotics, thyroid hormones, dopamine compounds (modafinil and lisdexamfetamine) and lithium. Acceptability was lower with ziprasidone, mirtazapine, and cariprazine. Further research and head-to-head studies should be considered to strengthen the best available options for TRD.

PubMed 34986373 ↗
Lancet · 2019 · Meta-analysis / systematic review
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis

Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.

PubMed 30712879 ↗
Br J Clin Pharmacol · 2021 · Meta-analysis / systematic review
Drug-drug interactions with warfarin: A systematic review and meta-analysis

Conclusion: This review found low to moderate certainty evidence supporting the interaction between warfarin and a small group of medications, which result in increased bleeding risk. PPIs are associated with reduced hospitalization for upper GI bleeding for patients taking warfarin. Further studies are required to better understand drug-drug interactions leading to thromboembolic outcomes or death.

PubMed 33769581 ↗
Registered clinical trials

143 human trials on ClinicalTrials.gov test Mirtazapine — 87 completed, 7 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.…”

Full label on DailyMed (NIH) ↗

FDA recalls

8 recalls of products named for Mirtazapine. Most recent:

  • 2020-04-22 · Class II: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed record ↗
  • 2019-12-18 · Class I: Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg… record ↗
  • 2017-03-15 · Class II: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

91,057 adverse-event reports mention Mirtazapine. Most often reported:

  • Nausea · 5,028
  • Fatigue · 4,904
  • Drug ineffective · 4,786
  • Fall · 4,168
  • Diarrhoea · 4,111
  • Off label use · 3,999

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Mirtazapine C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 6 research projects with Mirtazapine in the title, $10,431,380 in total (1998–2021). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Mirtazapine ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

drowsiness ×6fatigue ×5weight gain ×4brain fog ×3rebound insomnia ×2tolerance ×2rls exacerbation ×2pssd ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Mirtazapine worked great for me, I'd credit it with saving my life.”
HelpedRead the discussion ↗
“The only drugs that has helped at all so far have been Buspar and Remeron, both of which eventually stopped working for me.”
MixedRead the discussion ↗
“The only one that really helped me was mirtazapine but I piled on the weight.”
HelpedRead the discussion ↗
“A med like Remeron (I had HORRIBLE side effects) uses several of my mutated/broken metabolizers.”
Didn't helpRead the discussion ↗
Read more Mirtazapine reviews →
Top discussions (5)

Other options for sleep

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate